Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: To combat invading pathogens, cells develop an adaptive immune response by changing their own genetic information. In vertebrates, the generation of genetic variation (somatic hypermutation) is an essential process for diversification and affinity maturation of antibodies that function to detect and sequester various foreign biomolecules. The activation-induced cytidine deaminase (AID) carries out hypermutation by modifying deoxycytidine bases in the variable region of the immunoglobulin locus that produces antibody. AID-generated deoxyuridine in DNA is mutagenic as it can be miss-recognized as deoxythymine, resulting in C to T mutations. CRISPR (clustered regularly interspaced short palindromic repeats)/Cas (CRISPR-associated) is a prokaryotic adaptive immune system that records and degrades invasive foreign DNA or RNA. The CRISPR/Cas system cleaves and incorporates foreign DNA/RNA segments into the genomic region called the CRISPR array. The CRISPR array is transcribed to produce crispr-RNA that serves as guide RNA (gRNA) for recognition of the complementary foreign DNA/RNA in a ribonucleoprotein complex with Cas proteins, which degrade the target. The CRISPR/Cas system has been repurposed as a powerful genome editing tool, because it can be programmed to cleave specific DNA sequence by providing custom gRNAs. RATIONALE: Although the precise mechanism by which AID specifically mutates the immunoglobulin locus remains elusive, targeting of AID activity is facilitated by the formation of a single-stranded DNA region, such as a transcriptional RNA/DNA hybrid (R-loop). The CRISPR/Cas system can be engineered to be nuclease-inactive. The nuclease-inactive form is capable of unfolding the DNA double strand in a protospacer adjacent motif (PAM) sequence-dependent manner so that the gRNA binds to complementary target DNA strand and forms an R-loop. The nuclease-deficient CRISPR/Cas system may serve as a suitable DNA-targeting module for AID to catalyze site-specific mutagenesis. RESULTS: To determine whether AID activity can be specifically targeted by the CRISPR/Cas system, we combined dCas9 (a nuclease-deficient mutant of Cas9) from Streptococcus pyogenes and an AID ortholog, PmCDA1 from sea lamprey, to form a synthetic complex (Target-AID) by either engineering a fusion between the two proteins or attaching a SH3 (Src 3 homology) domain to the C terminus of dCas9 and a SHL (SH3 interaction ligand) to the C terminus of PmCDA1. Both of these complexes performed highly efficient site-directed mutagenesis. The mutational spectrum was analyzed in yeast and demonstrated that point mutations were dominantly induced at cytosines within the range of three to five bases surrounding the –18 position upstream of the PAM sequence on the noncomplementary strand to gRNA. The toxicity associated with the nuclease-based CRISPR/Cas9 system was greatly reduced in the Target-AID complexes. Combination of PmCDA1 with the nickase Cas9(D10A) mutant, which retains cleavage activity for noncomplementary single-stranded DNA, was more efficient in yeast but also induced deletions as well as point mutations in mammalian cells. Addition of the uracil DNA glycosylase inhibitor protein, which blocks the initial step of the uracil base excision repair pathway, suppressed collateral deletions and further improved targeting efficiency. Potential off-target effects were assessed by whole-genome sequencing of yeast as well as deep sequencing of mammalian cells for regions that contain mismatched target sequences. These results showed that off-target effects were comparable to those of conventional CRISPR/Cas systems, with a reduced risk of indel formation. CONCLUSION: By expanding the genome editing potential of the CRISPR/Cas9 system by deaminase-mediated hypermutation, Target-AID demonstrated a very narrow range of targeted nucleotide substitution without the use of template DNA. Nickase Cas9 and uracil DNA glycosylase inhibitor protein can be used to boost the targeting efficiency. The reduced cytotoxicity will be beneficial for use in cells that are sensitive to artificial nucleases. Use of other types of nucleotide-modifying enzymes and/or other CRISPR-related systems with different PAM requirements will expand our genome-editing repertoire and capacity. A crippled CRISPR/Cas targets AID.: In vertebrate adaptive immunity, cytosine deaminase (AID or PmCDA1) induces somatic hypermutation at single-stranded DNA regions formed during transcription. The bacterial CRISPR/Cas9 immunity system recognizes and cleaves invasive DNA in a gRNA-dependent manner. AID and nuclease-deficient CRISPR/Cas9 are engineered to form a hybrid complex (Target-AID) that performs programmable cytosine mutations in a range of a few bases surrounding the –18 position upstream of PAM sequence of the noncomplementary DNA strand.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The second study used CRISPR-Cas9-mediated genome editing to remove a mutation in exon 23 in the mdx mouse model of DMD, providing partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle 25,26,49 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
In the citing paper
“Alternatives to DNA cleavage-induced editing include using CRISPR-Cas9 for direct chemical sequence alteration (base editing) 25,26 , providing RNA templates for gene alteration (prime editing) 27,28 , and for transcriptional control (CRISPR interference, CRISPRi; CRISPR activation, CRISPRa) 29,30 (Fig. 3).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
In the citing paper
“An alternative approach is to use CRISPR-Cas9 coupled to DNA editing enzymes that catalyze targeted A-to-G or Cto-T genomic sequence changes without inducing a break in DNA, potentially reversing pathogenic single-nucleotide changes or disabling genes via the introduction of a stop codon 25,26 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,474
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems
DiCarlo, J. E., Norville, J. E., Mali, P., Rios, X., Aach, J., & Church, G. M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt135 · Cited by 1,566
Synthetic protein scaffolds provide modular control over metabolic flux
Dueber, J. E., Wu, G. C., Malmirchegini, G. R., Moon, T. S., Petzold, C. J., Ullal, A. V., Prather, K. L. J., & Keasling, J. D. (2009) · Nature Biotechnology · doi:10.1038/nbt.1557 · Cited by 1,242
Cas9 as a versatile tool for engineering biology
Mali, P., Esvelt, K. M., & Church, G. M. (2013) · Nature Methods · doi:10.1038/nmeth.2649 · Cited by 1,197
Cited by
Items 401–500 of 1,001
David, F., Davis, A. M., Gossing, M., Hayes, M. A., Romero, E., Scott, L. H., & Wigglesworth, M. J. (2021) · SLAS DISCOVERY · doi:10.1177/24725552211000669 · Cited by 50
Advances in genome editing for genetic hearing loss
Ding, N., Lee, S., Lieber-Kotz, M., Yang, J., & Gao, X. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.001 · Cited by 45
Jiang, C., Wang, F., Zhang, K., Min, T., Chen, D., & Wen, Y. (2021) · ACS Sensors · doi:10.1021/acssensors.1c00624 · Cited by 44
Base Editors for Citrus Gene Editing
Huang, X., Wang, Y., & Wang, N. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.852867 · Cited by 54
Precise Genome Editing in Poultry and Its Application to Industries
Park, J. S., Lee, K. Y., & Han, J. Y. (2020) · Genes · doi:10.3390/genes11101182 · Cited by 49
Development of a base editor for protein evolution via in situ mutation in vivo
Hao, W., Cui, W., Cheng, Z., Han, L., Suo, F., Liu, Z., Zhou, L., & Zhou, Z. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab673 · Cited by 43
Off-target effects of base editors: what we know and how we can reduce it
Slesarenko, Y. S., Лавров, А. В., & Smirnikhina, S. (2021) · Current Genetics · doi:10.1007/s00294-021-01211-1 · Cited by 47
CRISPR-Cas System: The Current and Emerging Translational Landscape
Bhokisham, N., Laudermilch, E., Traeger, L. L., Bonilla, T. D., Ruíz-Estévez, M., & Becker, J. R. (2023) · Cells · doi:10.3390/cells12081103 · Cited by 55
Kawabe, Y., Komatsu, S., Komatsu, S., Murakami, M., Itô, A., Sakuma, T., Nakamura, T., Yamamoto, T., & Kamihira, M. (2017) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2017.12.003 · Cited by 45
Inheritance of co-edited genes by CRISPR-based targeted nucleotide substitutions in rice
Shimatani, Z., Fujikura, U., Ishii, H., Matsui, Y., Suzuki, M., Ueke, Y., Taoka, K.-I., Terada, R., Nishida, K., & Kondo, A. (2018) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2018.04.028 · Cited by 44
Self-citationRaikwar, S. P., Kikkeri, N. S., Sakuru, R. C., Saeed, D., Zahoor, H., Premkumar, K., Mentor, S., Thangavel, R., Dubova, I., Ahmed, M. E., et al. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09849-y · Cited by 54
Using Gene Editing Approaches to Fine-Tune the Immune System
Pavlovic, K., Tristán‐Manzano, M., Maldonado‐Pérez, N., Cortijo-Gutierréz, M., Sánchez-Hernández, S., Justicia-Lirio, P., Carmona-Luque, M. D., Herrera, C., Martín, F., & Benabdellah, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.570672 · Cited by 54
Prime editing primarily induces undesired outcomes in mice
Aida, T., Wilde, J. J., Yang, L., Hou, Y., Li, M., Xu, D., Lin, J., Qi, P., Lu, Z., & Feng, G. (2020) · doi:10.1101/2020.08.06.239723 · Cited by 43
Wang, P., Xu, L. M., Gao, Y., & Han, R. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.04.009 · Cited by 45
A Cas3-base editing tool for targetable in vivo mutagenesis
Zimmermann, A., Prieto-Vivas, J. E., Cautereels, C., Gorkovskiy, A., Steensels, J., de Peer, Y. V., & Verstrepen, K. J. (2023) · Nature Communications · doi:10.1038/s41467-023-39087-z · Cited by 49
Wu, Y., Xu, W., Wang, F., Zhao, S., Feng, F., Song, J., Zhang, C., & Yang, J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00379 · Cited by 40
Bradbury, A., Clapp, O., Biacsi, A.-S., Kuo, P. C., Gaju, O., Hayta, Ş., Zhu, J., & Lambing, C. (2025) · Plant Communications · doi:10.1016/j.xplc.2025.101386 · Cited by 51
CRISPR RNA-guided autonomous delivery of Cas9
Wilkinson, R. A., Martin, C. D., Nemudryi, A. A., & Wiedenheft, B. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0173-y · Cited by 48
GOTI, a method to identify genome-wide off-target effects of genome editing in mouse embryos
Zuo, E., Sun, Y., Wu, W., Yuan, T., Ying, W., Sun, H., Yuan, L., Steinmetz, L. M., Li, Y., & Yang, H. (2020) · Nature Protocols · doi:10.1038/s41596-020-0361-1 · Cited by 45
Regulation of germination by targeted mutagenesis of grain dormancy genes in barley
Hisano, H., Hoffie, R. E., Abe, F., Munemori, H., Matsuura, T., Endo, M., Mikami, M., Nakamura, S., Kumlehn, J., & Sato, K. (2021) · Plant Biotechnology Journal · doi:10.1111/pbi.13692 · Cited by 46
Liu, L., Zou, L., Li, K., Hou, H., Hu, Q., Liu, S., Li, J., Song, C., Chen, J., Wang, S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111061 · Cited by 40
Current advances in gene therapy of mitochondrial diseases
Soldatov, V. O., Kubekina, M. V., Skorkina, M. Y., Белых, А. Е., Egorova, T. V., Корокин, М. В., Pokrovskiy, M. V., Deykin, A. V., & Angelova, P. R. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03685-0 · Cited by 48
Haider, S., & Mussolino, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094067 · Cited by 51
Yeast genetic interaction screens in the age of CRISPR/Cas
Adames, N. R., Gallegos, J. E., & Peccoud, J. (2018) · Current Genetics · doi:10.1007/s00294-018-0887-8 · Cited by 42
R-loop formation by dCas9 is mutagenic in Saccharomyces cerevisiae
Laughery, M. F., Mayes, H. C., Pedroza, I. K., & Wyrick, J. J. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1278 · Cited by 40
Yang, J., Kim, B., Kim, G. Y., Jung, G. Y., & Seo, S. W. (2019) · Biotechnology for Biofuels · doi:10.1186/s13068-019-1460-5 · Cited by 43
Tandem Paired Nicking Promotes Precise Genome Editing with Scarce Interference by p53
Hyodo, T., Rahman, M. L., Karnan, S., Ito, T., Toyoda, A., Ota, A., Wahiduzzaman, M., Tsuzuki, S., Okada, Y., Hosokawa, Y., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.064 · Cited by 45
Wide Horizons of CRISPR-Cas-Derived Technologies for Basic Biology, Agriculture, and Medicine
Molla, K. A., Karmakar, S., & Islam, T. (2020) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-0716-0616-2_1 · Cited by 61
Highly efficient generation of sheep with a defined FecBB mutation via adenine base editing
Zhou, S., Ding, Y., Liu, J., Liu, Y., Zhao, X., Li, G., Zhang, C., Li, C., Wang, Y., Kalds, P., et al. (2020) · Genetics Selection Evolution · doi:10.1186/s12711-020-00554-6 · Cited by 53
Kim, D., Kang, B., & Kim, J. (2021) · Nature Protocols · doi:10.1038/s41596-020-00453-6 · Cited by 46
Sun, N., Zhao, D., Li, S., Zhang, Z., Bi, C., & Zhang, X. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.03.023 · Cited by 41
The Bibliometric Landscape of Gene Editing Innovation and Regulation in the Worldwide
Wei, X., Pu, A., Liu, Q., Hou, Q., Zhang, Y., An, X., Long, Y., Jiang, Y., Dong, Z., Wu, S., et al. (2022) · Cells · doi:10.3390/cells11172682 · Cited by 42
A most formidable arsenal: genetic technologies for building a better mouse
Clark, J. F., Dinsmore, C. J., & Soriano, P. M. (2020) · Genes & Development · doi:10.1101/gad.342089.120 · Cited by 45
Genome engineering of stem cell organoids for disease modeling
Sun, Y., & Ding, Q. (2017) · Protein & Cell · doi:10.1007/s13238-016-0368-0 · Cited by 39
“Cells react to DSBs by initiating DNA repair processes, either through non-homology end joining (NHEJ) or homology directed recombination (HDR).”
MethodInfluentialThe Design and Application of DNA-Editing Enzymes as Base Editors
Rallapalli, K. L., & Komor, A. C. (2023) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052521-013938 · Cited by 44
Base editor screens for in situ mutational scanning at scale
Lue, N. Z., & Liau, B. B. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.06.009 · Cited by 38
Liu, Z., Zhang, Y., & Nielsen, J. (2019) · Biochemistry · doi:10.1021/acs.biochem.8b01236 · Cited by 41
Mitsui, R., Yamada, R., & Ogino, H. (2019) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-019-2688-8 · Cited by 42
CRISPR/Cas Derivatives as Novel Gene Modulating Tools: Possibilities and In Vivo Applications
Xu, X., Hulshoff, M. S., Tan, X., Zeisberg, M., & Zeisberg, E. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093038 · Cited by 44
Multiplex precise base editing in cynomolgus monkeys
Zhang, W., Aida, T., del Rosario, R. C. H., Wilde, J. J., Ding, C., Zhang, X., Baloch, Z., Huang, Y., Tang, Y., Li, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16173-0 · Cited by 46
A Tale of Two Moieties: Rapidly Evolving CRISPR/Cas-Based Genome Editing
Yang, L. C., & Chen, J. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.06.003 · Cited by 40
Recording of elapsed time and temporal information about biological events using Cas9
Park, J., Lim, J. M., Jung, I., Heo, S., Park, J., Chang, Y. J., Kim, H. K., Jung, D., Yu, J. H., Min, S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.014 · Cited by 40
Engineered Campylobacter jejuni Cas9 variant with enhanced activity and broader targeting range
Nakagawa, R., Ishiguro, S., Okazaki, S., Mori, H., Tanaka, M., Aburatani, H., Yachie, N., Nishimasu, H., & Nureki, O. (2022) · Communications Biology · doi:10.1038/s42003-022-03149-7 · Cited by 44
Self-citationApplication and development of genome editing technologies to the Solanaceae plants
Yamamoto, T., Kashojiya, S., Kamimura, S., Kameyama, T., Ariizumi, T., Ezura, H., & Miura, K. (2018) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2018.02.019 · Cited by 42
Myoediting: Toward Prevention of Muscular Dystrophy by Therapeutic Genome Editing
Zhang, Y., Long, C., Bassel‐Duby, R., & Olson, E. N. (2018) · Physiological Reviews · doi:10.1152/physrev.00046.2017 · Cited by 45
The Mechanisms of Genome Editing Technologies in Crop Plants
Ahmad, Y., Haider, S., Iqbal, J., Abbasi, B. A., Yaseen, T., & Mahmood, T. (2022) · Springer eBooks · doi:10.1007/978-3-030-96925-7_13 · Cited by 46
CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy
Chen, C., Wang, Z., & Qin, Y. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00457-4 · Cited by 49
Shen, Q., Ruan, H., Zhang, H., Wu, T., Zhu, K., Han, W., Dong, R., Ming, T., Qi, H., & Zhang, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1375120 · Cited by 38
Minimizing the ratio of ionizable lipid in lipid nanoparticles for in vivo base editing
Chen, Q., Wang, X., Zhang, Y., Tian, M., Duan, J., Zhang, Y., & Yin, H. (2024) · National Science Review · doi:10.1093/nsr/nwae135 · Cited by 42
Musunuru, K. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.002 · Cited by 44
Liu, L. D., Huang, M., Dai, P., Liu, T., Fan, S., Cheng, X., Zhao, Y., Yeap, L.-S., & Meng, F.-L. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.090 · Cited by 38
Targeted Base Editing via RNA-Guided Cytidine Deaminases in Xenopus laevis Embryos.
Park, D., Yoon, M.-J., Kweon, J., Jang, A.-H., Kim, Y., & Choi, S. (2017) · PubMed · doi:10.14348/molcells.2017.0262 · Cited by 38
Inhibitors of DNA Glycosylases as Prospective Drugs
Mechetin, G. V., Endutkin, A. V., Diatlova, E. A., & Zharkov, D. O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093118 · Cited by 43
Improving Horticultural Crops via CRISPR/Cas9: Current Successes and Prospects
Bhatta, B. P., & Malla, S. (2020) · Plants · doi:10.3390/plants9101360 · Cited by 53
CRISPR FokI Dead Cas9 System: Principles and Applications in Genome Engineering
Saifaldeen, M., Al-Ansari, D. E., Ramotar, D., & Aouida, M. (2020) · Cells · doi:10.3390/cells9112518 · Cited by 42
Base editing and prime editing in laboratory animals
Caso, F., & Davies, B. (2021) · Laboratory Animals · doi:10.1177/0023677221993895 · Cited by 42
Otto, M., Skrekas, C., Gossing, M., Gustafsson, J., Siewers, V., & David, F. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00408 · Cited by 39
Salman, A., Kantor, A., McClements, M. E., Marfany, G., Trigueros, S., & MacLaren, R. E. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091842 · Cited by 37
Application of CRISPR/Cas9 System in Establishing Large Animal Models
Lin, Y., Li, J., Li, C., Tu, Z., Li, S., Li, X., & Yan, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.919155 · Cited by 47
Applications and Prospects of CRISPR/Cas9-Mediated Base Editing in Plant Breeding
Li, Y., Liang, J. Y., Deng, B., Jiang, Y., Zhu, J., Chen, L., Li, M., & Li, J. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45020059 · Cited by 48
Revolutionising healing: Gene Editing's breakthrough against sickle cell disease
Dimitrievska, M., Bansal, D., Vitale, M., Strouboulis, J., Miccio, A., Nicolaides, K. H., Hoss, S. E., Shangaris, P., & Jackow, J. (2024) · Blood Reviews · doi:10.1016/j.blre.2024.101185 · Cited by 46
Gee, P., Xu, H., & Hotta, A. (2017) · Stem Cells International · doi:10.1155/2017/8765154 · Cited by 39
Gene Editing With TALEN and CRISPR/Cas in Rice
Bi, H., & Yang, B. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.04.006 · Cited by 47
Xu, W., Yang, Y., Liu, Y., Kang, G., Wang, F., Li, L., Lv, X., Zhao, S., Yuan, S., Song, J., et al. (2019) · Molecular Plant · doi:10.1016/j.molp.2019.10.007 · Cited by 37
Docking sites inside Cas9 for adenine base editing diversification and RNA off-target elimination
Li, S., Yuan, B., Cao, J., Chen, J., Chen, J., Qiu, J., Zhao, X., Wang, X., Qiu, Z., & Cheng, T. (2020) · Nature Communications · doi:10.1038/s41467-020-19730-9 · Cited by 38
Guide-target mismatch effects on dCas9–sgRNA binding activity in living bacterial cells
Feng, H., Guo, J., Wang, T., Zhang, C., & Xing, X. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1295 · Cited by 38
Cis- and trans-factors affecting AID targeting and mutagenic outcomes in antibody diversification
Yeap, L.-S., & Meng, F. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.01.002 · Cited by 35
Precise and broad scope genome editing based on high-specificity Cas9 nickases
Wang, Q., Liu, J., Janssen, J. M., Le Bouteiller, M., Frock, R. L., & Gonçalves, M. A. F. V. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1236 · Cited by 41
CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing
Dasgupta, I., Flotte, T. R., & Keeler, A. M. (2021) · Human Gene Therapy · doi:10.1089/hum.2021.013 · Cited by 40
Helicase-AID: A novel molecular device for base editing at random genomic loci
Wang, J., Zhao, D., Li, J., Hu, M., Xin, X., Price, M. A., Li, Q., Liu, L., Li, S., Rosser, S. J., et al. (2021) · Metabolic Engineering · doi:10.1016/j.ymben.2021.08.005 · Cited by 37
Imperfect guide-RNA (igRNA) enables CRISPR single-base editing with ABE and CBE
Zhao, D., Jiang, G., Li, J., Chen, X., Li, S., Wang, J., Zhou, Z., Pu, S., Dai, Z., Ma, Y., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac201 · Cited by 42
Current advances of CRISPR-Cas technology in cell therapy
Qiu, H.-Y., Ji, R.-J., & Zhang, Y. (2022) · Cell Insight · doi:10.1016/j.cellin.2022.100067 · Cited by 41
TadA reprogramming to generate potent miniature base editors with high precision
Zhang, S., Song, L., Yuan, B., Zhang, C., Cao, J., Chen, J., Qiu, J., Tai, Y., Chen, J., Qiu, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36004-2 · Cited by 42
Multiplexed base editing through Cas12a variant-mediated cytosine and adenine base editors
Chen, F., Lian, M., Ma, B., Gou, S., Luo, X., Yang, K., Shi, H., Xie, J., Ge, W., Ouyang, Z., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04152-8 · Cited by 40
Cytosine base editors induce off-target mutations and adverse phenotypic effects in transgenic mice
Yan, N., Feng, H., Sun, Y., Xin, Y., Zhang, H., Lu, H., Zheng, J., He, C., Zuo, Z., Yuan, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37508-7 · Cited by 38
Chen, Z., Kelly, K., Cheng, H., Dong, X., Hedger, A. K., Li, L., Sontheimer, E. J., & Watts, J. K. (2023) · GEN Biotechnology · doi:10.1089/genbio.2023.0045 · Cited by 41
Assessing and engineering the IscB–ωRNA system for programmed genome editing
Yan, H., Tan, X., Zou, S., Sun, Y., Ke, A., & Tang, W. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01669-3 · Cited by 40
Functional interrogation of non-coding DNA through CRISPR genome editing
Canver, M. C., Bauer, D. E., & Orkin, S. H. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.008 · Cited by 39
From fiction to science: clinical potentials and regulatory considerations of gene editing
Schacker, M., & Seimetz, D. (2019) · Clinical and Translational Medicine · doi:10.1186/s40169-019-0244-7 · Cited by 39
Context-Dependent Strategies for Enhanced Genome Editing of Genodermatoses
March, O. P., Köcher, T., & Koller, U. (2020) · Cells · doi:10.3390/cells9010112 · Cited by 38
CRISPR/Cas9-mediated targeted mutagenesis in Japanese cedar (Cryptomeria japonica D. Don)
Nanasato, Y., Mikami, M., Futamura, N., Endo, M., Nishiguchi, M., Ohmiya, Y., Konagaya, K.-I., & Taniguchi, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-95547-w · Cited by 39
Zhang, C., Li, N., Rao, L., Li, J., Liu, Q., & Tian, C. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02321-21 · Cited by 50
Matuszek, Ż., Arbab, M., Kesavan, M., Hsu, A., Roy, J. C. L., Zhao, J., Yu, T., Weisburd, B., Newby, G. A., Doherty, N. J., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02172-8 · Cited by 42
DNA, RNA, and Protein Tools for Editing the Genetic Information in Human Cells
Chen, X., & Gonçalves, M. A. F. V. (2018) · iScience · doi:10.1016/j.isci.2018.08.001 · Cited by 37
Programmable adenine deamination in bacteria using a Cas9–adenine-deaminase fusion
Zhang, Y. P., Zhang, H., Wang, Z., Wu, Z., Wang, Y., Tang, N., Xu, X., Zhao, S., Chen, W., & Ji, Q. (2020) · Chemical Science · doi:10.1039/c9sc03784e · Cited by 34
Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a
Swartjes, T., Staals, R. H. J., & John van der, O. O. S. T. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190563 · Cited by 39
Genome Editing for CNS Disorders
Duarte, F. T., & Déglon, N. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.579062 · Cited by 36
Random Base Editing for Genome Evolution in Saccharomyces cerevisiae
Pan, Y., Xia, S., Dong, C., Pan, H., Cai, J., Huang, L., Xu, Z., & Lian, J. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00217 · Cited by 35
Strategies for precise gene edits in mammalian cells
Fichter, K. M., Setayesh, T., & Malik, P. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.04.012 · Cited by 37
CRISPR/Cas9 system and its applications in nervous system diseases
Jiang, H., Tang, M.-Y., Xu, Z., Wang, Y., Li, M., Zheng, S., Zhu, J., Lin, Z., & Zhang, M. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.03.017 · Cited by 43
Emerging Gene Therapeutics for Epidermolysis Bullosa under Development
Bischof, J., Hierl, M., & Koller, U. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042243 · Cited by 38
Wang, Y., Gao, R., Wu, J., Xiong, Y., Wei, J., Zhang, S., Yang, B., Chen, J., & Yang, L. C. (2019) · Genome biology · doi:10.1186/s13059-019-1839-4 · Cited by 33
Recent advances in mammalian reproductive biology
Wen, L., Liu, Q., Xu, J.-J., Liu, X., Shi, C.-Y., Yang, Z., Zhang, Y., Xu, H., Liu, J., Yang, H., et al. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-1572-7 · Cited by 35
Revisiting CRISPR/Cas-mediated crop improvement: special focus on nutrition
Kaul, T., Sony, S. K., Verma, R., Motelb, K. F. A., Prakash, A. T., Eswaran, M., Bharti, J., Nehra, M., & Kaul, R. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00094-7 · Cited by 33
“Active sites within distinctly-characterized proteins might be targeted by base editors (ABE/CBE), to evoke specific amino acid alterations for the creation of loss or gain-offunction alleles (Nishida et al. 2016; Shimatani et al. 2017; Zhong et al. 2018; Li et al 2018a).”
BackgroundMethodPrecision Genome Engineering for the Breeding of Tomatoes: Recent Progress and Future Perspectives
Vu, T. V., Das, S., Tran, M. T., Hong, J. C., & Kim, J. (2020) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.612137 · Cited by 41
Choi, M., Yun, J., Kim, J., Kim, J., & Kim, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-87669-y · Cited by 36
Shelake, R. M., Pramanik, D., & Kim, J. (2023) · mBio · doi:10.1128/mbio.02296-22 · Cited by 36
CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia
Chadwick, A. C., & Musunuru, K. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309326 · Cited by 34
Applications of Alternative Nucleases in the Age of CRISPR/Cas9
Guha, T. K., & Edgell, D. R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122565 · Cited by 42
Improving recombinant protein production in CHO cells using the CRISPR-Cas system
Kalkan, A. K., Palaz, F., Semeniuk, S., Elmousa, N., Ledezma, Y., Cachat, É., & Rios‐Solis, L. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108115 · Cited by 38
Metadata
- Authors
- Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K. Y., Shimatani, Z., & Kondo, A.
- Affiliations
- Kobe University (JP)
- Keio University (JP)
- Shizuoka University (JP)
- Corresponding author
- Kondo, Akihiko
- ORCID
- Venue
- Science
- Published
- 2016-09-16
- Volume
- 353
- Issue
- 6305
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2480829753
- Cited by
- 1,349
- References
- 27
- Citations by year
- 2026: 69 · 2025: 124 · 2024: 151 · 2023: 152 · 2022: 181 · 2021: 157 · 2020: 167 · 2019: 137 · 2018: 112 · 2017: 88 · 2016: 10
- FWCI
- 60.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports and Technology (MEXT) of Japan
- Ministry of Economy, Trade and Industry (METI), Japan
- JSPS KAKENHI (26119710, 16K14654)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- activation-induced cytidine deaminase, CRISPR/Cas9, dCas9, sea lamprey, somatic hypermutation, R-loops, site-directed mutagenesis, genome editing, immunoglobulin variable region, affinity maturation
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, AICDA (Activation-Induced Cytidine Deaminase), Alleles, Animals, Bacteria, Bacterial Proteins, Cricetulus, Cytidine, Cytidine Deaminase, Deoxyribonuclease I, DNA, Endonucleases, Enzyme Inhibitors, Immune System, RNA, Saccharomyces cerevisiae, Vertebrates, CHO Cells, Point Mutation, Gene Targeting, Uracil-DNA Glycosidase, INDEL Mutation, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.